Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

580 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of endovascular thrombectomy for primary and secondary MeVO.
Cascio Rizzo A, Schwarz G, Cervo A, Giussani G, Ceresa C, Gatti A, De Angeli F, Motto C, Guccione A, Tortorella R, Granata G, Rollo C, Macera A, Piano M, Pero G, Agostoni EC. Cascio Rizzo A, et al. Among authors: gatti a. J Stroke Cerebrovasc Dis. 2024 Jan;33(1):107492. doi: 10.1016/j.jstrokecerebrovasdis.2023.107492. Epub 2023 Nov 21. J Stroke Cerebrovasc Dis. 2024. PMID: 37988832
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial.
Sasso FC, Simeon V, Galiero R, Caturano A, De Nicola L, Chiodini P, Rinaldi L, Salvatore T, Lettieri M, Nevola R, Sardu C, Docimo G, Loffredo G, Marfella R, Adinolfi LE, Minutolo R; NID-2 study group Investigators. Sasso FC, et al. Cardiovasc Diabetol. 2022 Nov 7;21(1):235. doi: 10.1186/s12933-022-01674-7. Cardiovasc Diabetol. 2022. PMID: 36344978 Free PMC article. Clinical Trial.
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II.
Das S, Rruga F, Montepeloso A, Dimartino A, Spadini S, Corre G, Patel J, Cavalca E, Ferro F, Gatti A, Milazzo R, Galy A, Politi LS, Rizzardi GP, Vallanti G, Poletti V, Biffi A. Das S, et al. Among authors: gatti a. Mol Ther. 2024 Mar 6;32(3):619-636. doi: 10.1016/j.ymthe.2024.01.034. Epub 2024 Feb 3. Mol Ther. 2024. PMID: 38310355
Intraluminal carotid thrombus leading to postpartum stroke: a case study.
Poggetti F, Schwarz G, Piano M, Gatti A, Aquilano MC, Di Como M, Protti A, Bonoldi E, Agostoni EC, Cascio Rizzo A. Poggetti F, et al. Among authors: gatti a. Neurol Sci. 2024 Apr;45(4):1735-1739. doi: 10.1007/s10072-024-07335-9. Epub 2024 Jan 20. Neurol Sci. 2024. PMID: 38244118
580 results